- Condition: Cataract
Interventions: Drug: 40 mg/mL Dexamethasone phosphate ophthalmic solution; Drug: 100 mM sodium citrate buffer solution
Sponsors: Eyegate Pharmaceuticals, Inc.; Eyegate Pharmaceuticals, Inc.
Not yet recruiting - verified May 2012 - Condition: Dermatomyositis Associated Superficial Calcinosis
Interventions: Device: Fractional Carbon Dioxide (FCO2) Laser (Candela QuadraLase (TM)); Drug: Sodium thiosulfate
Sponsors: George Washington University; George Washington University
Not yet recruiting - verified April 2012 - Condition: Head and Neck Cancer
Interventions: Drug: Intra-arterial cisplatin; Drug: Intravenous cisplatin
Sponsors: Southern Illinois University; Southern Illinois University
Not yet recruiting - verified April 2012 - Conditions: End Stage Renal Disease; Kidney Failure; Renal Failure; Hyperphosphatemia; ESRD
Intervention: Drug: ferric citrate
Sponsors: Keryx Biopharmaceuticals; Keryx Biopharmaceuticals
Not yet recruiting - verified March 2012 - Condition: HIV-1 Infection
Intervention: Drug: Sevelamer carbonate
Sponsors: AIDS Clinical Trials Group; AIDS Clinical Trials Group; National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified February 2012 - Conditions: Secondary Hypogonadism; Low Testosterone
Interventions: Drug: enclomiphene citrate; Drug: Testosterone
Sponsors: Repros Therapeutics Inc.; Repros Therapeutics Inc.
Not yet recruiting - verified April 2012 - Condition: Acute Lymphoblastic Leukemia
Interventions: Drug: Everolimus; Drug: Prednisone; Drug: Vincristine; Drug: PEG-Asparaginase; Drug: Doxorubicin; Drug: Dexrazoxane
Sponsors: Dana-Farber Cancer Institute; Dana-Farber Cancer Institute; Novartis
Recruiting - verified January 2012 - Condition: Anterior Uveitis
Interventions: Drug: 40 mg/mL Dexamethasone phosphate ophthalmic solution; Drug: Prednisolone Acetate (1%) Eyedrops; Drug: 100 mM sodium citrate buffer solution; Drug: Placebo Eyedrops
Sponsors: Eyegate Pharmaceuticals, Inc.; Eyegate Pharmaceuticals, Inc.
Recruiting - verified May 2012 - Conditions: Gestational Diabetes; Obesity
Interventions: Dietary Supplement: Magnesium citrate; Dietary Supplement: Placebo; Behavioral: Dietary modification
Sponsors: University of California, Los Angeles; University of California, Los Angeles
Recruiting - verified January 2012 - Condition: Diabetic Nephropathy
Interventions: Drug: Sevelamer Carbonate; Drug: calcium carbonate
Sponsors: Mount Sinai School of Medicine; Gary Striker
Not yet recruiting - verified December 2011 - Condition: Chronic Kidney Disease
Interventions: Other: K2CG chewing gum (20mg chitosan); Other: K2CG chewing gum (60mg chitosan); Other: No intervention
Sponsors: Denver Nephrologists, P.C.; Denver Nephrologists, P.C.; CM&D Pharma Limited
Recruiting - verified November 2011 - Condition: Breast Cancer
Interventions: Radiation: 111 Indium CHX-A DTPA-Trastuzumab; Drug: 111Indium Trastuzumab
Sponsors: National Institutes of Health Clinical Center (CC); National Cancer Institute (NCI)
Recruiting - verified April 2012 - Condition: Chronic Kidney Disease Requiring Chronic Dialysis
Interventions: Drug: PA21; Drug: Sevelamer carbonate
Sponsors: Vifor Inc.; Vifor Inc.; Fresenius Medical Care North America
Recruiting - verified October 2011 - Condition: Sickle Cell Anemia
Intervention:
Sponsors: Novartis; Novartis Pharmaceuticals
Recruiting - verified December 2011 - Condition: Chronic Kidney Disease
Interventions: Drug: Phoslyra; Drug: Sevelamer Carbonate
Sponsors: Fresenius Medical Care North America; Fresenius Medical Care North America
Recruiting - verified March 2012 - Condition: Sickle Cell Anemia
Intervention: Drug: Hydroxyurea
Sponsors: Baylor College of Medicine; Baylor College of Medicine; National Heart, Lung, and Blood Institute (NHLBI); Children's Hospital Boston; Children's Hospital Medical Center, Cincinnati; University of Texas Southwestern Medical Center; Children's Healthcare of Atlanta; Children's Hospital of Philadelphia; The Hospital for Sick Children; Children's Research Institute; Columbia University; St. Jude Children's Research Hospital; Virginia Commonwealth University; Rainbow Babies Hospital; University of South Alabama; Medical University of South Carolina; Cohen Children's Medical Center; University of Alabama at Birmingham; University of Miami; University of Mississippi Medical Center; Wayne State University; Children's Hospital of The King's Daughters; Nemours Children's Clinic; Duke University; East Carolina University; Children's Hospitals and Clinics of Minnesota; Children's Memorial Hospital
Recruiting - verified March 2012 - Condition: Arthritis
Intervention: Drug: sodium citrate and citric acid
Sponsors: Texas Tech University Health Sciences Center; Texas Tech University Health Sciences Center
Recruiting - verified August 2011 - Condition: Cancer
Interventions: Procedure: Insertion of Pressure Equalization (PE) Tubes; Drug: Sodium Thiosulfate (STS); Other: Saline (Placebo); Drug: Cisplatin
Sponsors: Thomas Jefferson University; Thomas Jefferson University
Recruiting - verified January 2012 - Conditions: Transfusional Iron Overload; Beta-Thalassemia
Intervention: Drug: FBS0701
Sponsors: FerroKin BioSciences, Inc.; FerroKin BioSciences, Inc.
Recruiting - verified August 2011 - Conditions: Stroke; Problem of Aging
Intervention: Drug: desferrioxamine
Sponsors: Brigham and Women's Hospital; Brigham and Women's Hospital; National Institute on Aging (NIA)
Recruiting - verified June 2011 - Conditions: Myelodysplastic Syndrome,; Transfusional Iron Overload
Intervention: Drug: Deferasirox
Sponsors: Novartis; Novartis Pharmaceuticals
Recruiting - verified May 2012 - Condition: Superficial Siderosis
Intervention:
Sponsors: Johns Hopkins University; Johns Hopkins University
Not yet recruiting - verified February 2012 - Condition: Breast Cancer
Interventions: Drug: anastrozole; Drug: exemestane; Drug: letrozole; Drug: systemic chemotherapy; Drug: tamoxifen citrate
Sponsors: National Cancer Institute (NCI); Southwest Oncology Group; National Cancer Institute (NCI)
Recruiting - verified February 2012 - Condition: Chronic Kidney Disease
Interventions: Drug: Sevelamer carbonate; Drug: Calcium acetate
Sponsors: Albany College of Pharmacy and Health Sciences; Albany College of Pharmacy and Health Sciences; Albany Medical College; Genzyme
Recruiting - verified December 2011 - Conditions: Dialysis; Cardiovascular Disease; Atherosclerosis; Inflammation; Hyperphosphatemia
Intervention: Drug: Sevelamer Carbonate (Renvela)
Sponsors: Brigham and Women's Hospital; Brigham and Women's Hospital
Recruiting - verified June 2011 - Conditions: AML; ALL; CML in Blast Crisis; High-Risk MDS; Multiple Myeloma
Intervention: Drug: TG02 citrate
Sponsors: Tragara Pharmaceuticals, Inc.; Tragara Pharmaceuticals, Inc.
Recruiting - verified December 2011 - Conditions: Hyperparathyroidism; Chronic Kidney Disease
Interventions: Drug: sevelamer carbonate; Drug: placebo
Sponsors: Phelps, Kenneth R., M.D.; Phelps, Kenneth R., M.D.
Recruiting - verified June 2011 - Condition: Sarcoma, Soft Tissue
Interventions: Biological: IMC-3G3; Drug: doxorubicin; Drug: dexrazoxane
Sponsors: ImClone LLC; ImClone LLC
Recruiting - verified April 2012 - Conditions: Autism; Gastrointestinal Symptoms
Interventions: Other: GFCF product with GFCF diet; Other: product containing gluten and casein (milk protein) with GFCF diet
Sponsors: Massachusetts General Hospital; Massachusetts General Hospital; Nutricia North America
Recruiting - verified March 2012 - Conditions: Non Hodgkin's Lymphoma; NHL; Aggressive NHL
Intervention: Drug: Veltuzumab and 90Y-Epratuzumab Tetraxetan
Sponsors: Immunomedics, Inc.; Immunomedics, Inc.
Recruiting - verified February 2012 - Condition: Wound Debridement
Interventions: Device: HemCon Dressings and HemCon ChitoGauze; chitosan-based.; Device: HemCon Dressings and HemCon ChitoGauze; chitosan-based.; Device: Gauze and saline dressings.; Device: Gauze and saline dressings.
Sponsors: HemCon Medical Technologies, Inc; HemCon Medical Technologies, Inc
Recruiting - verified June 2011 - Conditions: Central Nervous System Embryonal Tumor; Germ Cell Tumors
Interventions: Drug: Melphalan; Drug: Carboplatin; Drug: Sodium thiosulfate; Drug: Filgrastim; Drug: Pegfilgrastim
Sponsors: OHSU Knight Cancer Institute; OHSU Knight Cancer Institute
Recruiting - verified January 2012 - Condition: Myelodysplastic Syndromes
Interventions: Drug: Deferasirox; Drug: Deferasirox placebo
Sponsors: Novartis; Novartis Pharmaceuticals
Recruiting - verified March 2012 - Conditions: Brain and Central Nervous System Tumors; Childhood Germ Cell Tumor; Extragonadal Germ Cell Tumor; Liver Cancer; Neuroblastoma; Ototoxicity; Ovarian Cancer; Sarcoma
Interventions: Drug: sodium thiosulfate; Procedure: examination
Sponsors: National Cancer Institute (NCI); Children's Oncology Group; National Cancer Institute (NCI)
Recruiting - verified May 2012 - Conditions: Transfusional Iron Overload; Transfusional Hemosiderosis
Interventions: Drug: Deferasirox; Drug: Deferoxamine
Sponsors: Novartis; Novartis Pharmaceuticals
Recruiting - verified April 2012 - Condition: Thalassemia
Interventions: Drug: Busulfan; Drug: Fludarabine; Drug: Campath 1H; Drug: Cyclophosphamide; Drug: MESNA; Procedure: Bone marrow or stem cell infusion
Sponsors: Baylor College of Medicine; Baylor College of Medicine; Texas Children's Hospital
Recruiting - verified May 2012 - Conditions: Brain and Central Nervous System Tumors; Breast Cancer; Cognitive/Functional Effects; Drug/Agent Toxicity by Tissue/Organ; Psychosocial Effects of Cancer and Its Treatment
Interventions: Biological: trastuzumab; Drug: carboplatin; Drug: methotrexate; Drug: sodium thiosulfate
Sponsors: OHSU Knight Cancer Institute; OHSU Knight Cancer Institute; National Cancer Institute (NCI)
Not yet recruiting - verified March 2012 - Condition: Brain and Central Nervous System Tumors
Interventions: Drug: Etoposide phosphate; Drug: Melphalan; Drug: Carboplatin; Drug: Sodium thiosulfate; Drug: Filgrastim; Drug: Pegfilgrastim
Sponsors: OHSU Knight Cancer Institute; OHSU Knight Cancer Institute; National Cancer Institute (NCI)
Recruiting - verified January 2012 - Conditions: Brain and Central Nervous System Tumors; Lymphoma
Interventions: Drug: Rituxan; Drug: Carboplatin; Drug: Methotrexate; Drug: Sodium thiosulfate; Drug: Neupogen; Drug: Neulasta; Drug: Leucovorin
Sponsors: OHSU Knight Cancer Institute; OHSU Knight Cancer Institute; National Cancer Institute (NCI)
Recruiting - verified January 2012 - Condition: Pulmonary Arterial Hypertension
Interventions: Drug: Sildenafil citrate; Drug: Sildenafil citrate; Drug: Sildenafil citrate
Sponsors: Pfizer; Pfizer
Recruiting - verified April 2012 - Conditions: Brain and Central Nervous System Tumors; Thrombocytopenia
Interventions: Drug: Carboplatin; Drug: Cyclophosphamide; Drug: Etoposide phosphate; Drug: Etoposide; Drug: Sodium thiosulfate
Sponsors: OHSU Knight Cancer Institute; OHSU Knight Cancer Institute; National Cancer Institute (NCI)
Recruiting - verified January 2012 - Conditions: Cutaneous T Cell Lymphoma; Hodgkin's Disease; Neoplasm; Non Hodgkin's Lymphoma; Peripheral T Cell Lymphoma
Interventions: Drug: Y-90 Humanized Anti-Tac; Drug: Calcium-DTPA
Sponsors: National Institutes of Health Clinical Center (CC); National Cancer Institute (NCI)
Recruiting - verified July 2011
 |
Chelating Clinical Trials |
